Because of Blood Clots, FDA and CDC Recommend Pausing Johnson & Johnson COVID Vaccine
*As many Americans continue to get vaccinated on the daily basis, the #CDC and the #FDA have issued a joint statement where they are recommending a pause on the use of the Johnson & Johnson COVID-19 vaccine Janssen after six reported U.S. cases of a rare and severe type of blood clot in individuals. In the statement, it was noted that all six cases of the rare and severe type of blood clots occurred in women from the ages of 18 and 48, and the symptoms occurred 6 to 13 days after they were...
United States Byfisher Jack Advisory Committee On Immunization Practices Blood Clots Pausing Johnson Advisory Committee
Source: eurweb.com